SEROLOGIC RESPONSE AND SAFETY AFTER THIRD DOSE OF THE COVID-19 BNT162B2 VACCINE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES

Hadar Edelman-Klapper  ¹     Keren Masha Rabinowitz  ¹     Eran Zittan  ²     Ariella Bar Gil Shitrit  ³     Idan Goren  ¹     Irit Avni-Biron  ¹     Jacob E. Ollech  ¹     Lev Lichtenstein  ⁴     Hagar Banai-Eran     Henit Yanai     Yifat Snir     Maor H. Pauker     Adi Friedenberg     Adva Levy-Barda     Arie Segal     Yelena Broitman     Eran Maoz     Baruch Ovadia     Maya Aharoni Golan     Eyal     
¹ Rabin Medical Center, Petah Tikva, Israel
² Emek Medical Center, Afula, Israel
³ Shaare Zedek Medical Center, Jerusalem, Israel
⁴ Clalit Health Services, Petah Tikva

Session
Covid-19 in IBD (Posters)

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)